# Relates to certain labelling requirements when substitute drug products are dispensed

**Bill ID:** A4804
**Session:** 2024
**Sponsor:** Robert Smullen
**Status:** In Assembly Committee
**PDF:** [A4804 PDF](https://legislation.nysenate.gov/pdf/bills/2024/A4804)

## Summary

Requires the brand name of a prescribed drug to be indicated on the label when substitute drug products are dispensed.

---

## Full Text

S T A T E  O F  N E W  Y O R K
 ________________________________________________________________________
 
  4804
 
  2023-2024 Regular Sessions
 
  I N  A S S E M B L Y
 
  February 23, 2023
  ___________
 
 Introduced  by M. of A. SMULLEN -- read once and referred to the Commit-
  tee on Consumer Affairs and Protection
 
 AN ACT to amend the education law, in relation to  certain  requirements
  when substitute drug products are dispensed
 
  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
  Section 1. Paragraph (c) of subdivision 1 of  section  6816-a  of  the
 education  law,  as added by chapter 776 of the laws of 1977, is amended
 to read as follows:
  (c) The pharmacist shall indicate on the label affixed to the  immedi-
 ate  container  in  which  the  drug  is  sold or dispensed the name and
 strength of the drug product and its manufacturer unless the  prescriber
 specifically states otherwise, AND SHALL ALSO INDICATE THE BRAND NAME OF
 THE  DRUG  PRESCRIBED.  The  pharmacist shall record on the prescription
 form the brand name or the name of the manufacturer of the drug  product
 dispensed.
  ยง  2.  This  act shall take effect on the thirtieth day after it shall
 have become a law.
 
 
 
 
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
  [ ] is old law to be omitted.
  LBD09605-01-3